Eli Lilly has announced plans to expand its domestic medicine production in the US by establishing four new pharmaceutical ...

Eli Lilly is building four new manufacturing sites, the drug company announced Wednesday, and though the $27 billion price ...

The pharmaceutical company expects the expansion will create thousands of jobs.

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...

Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by ...

Key Takeaways Eli Lilly plans to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the ...

Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...

The Indianapolis-based pharmaceutical company announced plans for four new manufacturing sites, but has not decided where ...

Indianapolis-based pharmaceutical giant Eli Lilly and Co. announced plans Wednesday to add four new manufacturing sites in a ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

Eli Lilly has lowered the price of its weight-loss drug Zepbound for patients paying out of pocket and introduced two new ...

At a press conference in Washington, D.C., Eli Lilly And Co (NYSE:LLY) announced its plans to bolster its domestic medicine ...